PATENT CLAIM ANALYSIS

Application Number: 15906438
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-07
Patent Classification: ["424", "426000"]

Abstract:
Disclosed herein are methods, processes, compositions, and kits for generating bone graft materials for use at a site of bone defect that utilizes a composition which contains liposomal Wnt polypeptide, such as liposomal Wnt3a polypeptide, liposomal Wnt5a polypeptide, or liposomal Wnt10b polypeptide. Also disclosed herein are methods, processes, compositions, and kits for enhancing mammalian bone marrow cells that utilizes a composition which contains liposomal Wnt polypeptide, such as liposomal Wnt3a polypeptide, liposomal Wnt5a polypeptide, or liposomal Wnt10b polypeptide.

Claim (Index 9):
The method of  claim 1 , wherein the purifying in step b) further comprises i) incubating the Wnt polypeptides on the column; and ii) eluting the Wnt polypeptides with an elution buffer comprising a salt concentration of from about 150 mM to about 2M.

Metadata:
- Claim Count in Document: 56.0
- Percentile: 88.0
- Lexical Diversity: 2.2439
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14910616', '15868395', '15063317', '14333220', '14337718']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7496464237785286
- 35 USC 102 Novelty (BERT): 0.6139522337413419
- Combined Prediction Score: 0.73607700477481
- Mean Citation Score: 459.294376
- Max Citation Score: 665.31616
- Similarity Product: 458.93304104873647

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test